These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1719592)

  • 1. Doxapram inhibits the in vitro oxidation of hexobarbital.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):371-4. PubMed ID: 1719592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-related differences in doxapram-induced alteration of drug action in the rat.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):397-400. PubMed ID: 2813960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
    Kaul KL; Novak RF
    J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
    Reidy GF; Mehta I; Murray M
    Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in testosterone oxidation in rat liver microsomes after prolonged administration of ethylmorphine].
    Pospelova LN; Chistiakov VV
    Biokhimiia; 1981 Feb; 46(2):347-52. PubMed ID: 7248389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hexobarbital-oxidation in vivo and in vitro in rats after phenobarbital-pretreatment or after portacaval anastomosis (author's transl)].
    Richter E; Gallenkamp H; Brachtel D; Grün M
    Z Gastroenterol; 1977 Jun; 15(6):389-92. PubMed ID: 888489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
    Parkinson A; Lasker J; Kramer MJ; Huang MT; Thomas PE; Ryan DE; Reik LM; Norman RL; Levin W; Conney AH
    Drug Metab Dispos; 1982; 10(6):579-85. PubMed ID: 6130903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the lipophilic spin-labeled inhibitor of cytochrome P-450 on the activity of the microsomal system].
    Subkhankulova TN; Liakhovich VV; Vaĭner LM
    Biokhimiia; 1987 Jul; 52(7):1186-91. PubMed ID: 3663758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations on the spectral interactions of fusarin C with rat liver microsomal cytochrome P-450.
    Gelderblom WC; Swart P; Kramer PS
    Xenobiotica; 1988 Sep; 18(9):1005-14. PubMed ID: 3227702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of manganese on hepatic drug metabolism in male and female rats.
    Schnell RC; Deimling MJ
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):307-15. PubMed ID: 6709965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of cyclobarbital and diazepam on drug metabolism in vitro and their binding to cytochrome P-450.
    Wierzba W; Müller D; Richter K; Klinger W
    Biomed Biochim Acta; 1984; 43(12):1425-30. PubMed ID: 6152537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic differences in the microsomal metabolism of the isomers of hexobarbital.
    McCarthy JS; Stitzel RE
    J Pharmacol Exp Ther; 1971 Mar; 176(3):772-8. PubMed ID: 5111462
    [No Abstract]   [Full Text] [Related]  

  • 13. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of phenobarbital on the impairment of drug metabolism by carrageenan-induced inflammation in male rat.
    Sasaki K; Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):377-80. PubMed ID: 2236905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of apparent kinetic constants of the microsomal hydroxylation of amobarbital, hexobarbital, and pentobarbital.
    Sitar DS; Mannering GJ
    Drug Metab Dispos; 1973; 1(5):663-8. PubMed ID: 4149704
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.
    Rush WR; Smith SA; Mulvey JH; Graham DJ; Chaplin MD
    Drug Metab Dispos; 1987; 15(4):571-8. PubMed ID: 2888633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.